Back to trial detailsIntake questionnaire
Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults
Applying to University of Pittsburgh CRS Site# 1001 · Pittsburgh, Pennsylvania
Answer a few short questions to share with the research team.
0 of 2 answered